(Q61922183)
Statements
A Six Month, Open Label, Randomized Parallel Group Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Or More Oral Agents (English)
0 references
March 2007
0 references
August 2008
0 references
413
0 references
30 year
0 references
75 year
0 references